Drug Shortage Report for RIVA-TADALAFIL

Last updated on 2021-12-02 History
Report ID 62666
Drug Identification Number 02454742
Brand name RIVA-TADALAFIL
Common or Proper name Riva-Tadalafil
Company Name LABORATOIRE RIVA INC.
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-09-28
Actual start date 2018-09-28
Estimated end date Unknown
Actual end date 2020-05-28
Shortage status Resolved
Updated date 2021-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 660 BOUL. INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-12-02 French Compare
v4 2021-12-02 English Compare
v3 2018-09-29 English Compare
v2 2018-09-28 French Compare
v1 2018-09-28 English Compare

Showing 1 to 5 of 5